Insider Transactions in Q1 2024 at Maxcyte, Inc. (MXCT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
John Joseph Johnston |
SELL
Open market or private sale
|
Direct |
5,000
-3.98%
|
$20,000
$4.41 P/Share
|
|
Mar 26
2024
|
John Joseph Johnston |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.83%
|
$10,000
$2.14 P/Share
|
|
Mar 15
2024
|
David I. Sandoval GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
3,913
+7.85%
|
-
|
|
Mar 15
2024
|
Thomas M. Ross EVP, GLOBAL SALES |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Mar 15
2024
|
Douglas J Swirsky CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
81,250
+50.0%
|
-
|
|
Feb 26
2024
|
John Joseph Johnston |
SELL
Open market or private sale
|
Direct |
5,000
-3.98%
|
$20,000
$4.6 P/Share
|
|
Feb 26
2024
|
John Joseph Johnston |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.83%
|
$10,000
$2.14 P/Share
|
|
Jan 26
2024
|
John Joseph Johnston |
SELL
Open market or private sale
|
Direct |
5,000
-3.98%
|
$25,000
$5.12 P/Share
|
|
Jan 26
2024
|
John Joseph Johnston |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.83%
|
$10,000
$2.14 P/Share
|